Preclinical work by Kortenoeven et al. demonstrated that demeclocycline reduces AQP2 expression via adenylate cyclase inhibition, leading to water diuresis and improved sodium in SIADH models [21]. Here, AQP2 is linked to inappropriate ADH syndrome.